Walking Pattern Characteristics in Normal Pressure Hydrocephalus
Key facts
- Who runs it
- University of Zurich
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 1 Jan 2018
- Ended
- 25 Apr 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Characterization of walking pattern characteristics in an ambulatory setting using wearable IMUs (ZurichMOVE sensors)
- Record updated
- 26 April 2024
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- NPH patient group:
- Informed Consent as documented by signature prior to any study related procedures or informed consent by a legal representative in case of cognitive deficits
- Male and female patients alike
- Age between 60 and 100 years
- Clinical suspect for NPH
- Significant improvement (by more than 10%) in walking speed or endurance in a standardized CSF-TAP test (of at least 35 ml CSF)
- Planned implantation of a VP shunt for NPH treatment (independently from the study); Matched controls group:
- Informed Consent as documented by signature prior to any study related procedures
- Male and female patients alike (matched to group 1)
- Age between 60 and 100 years (matched to group 1)
- No clinical suspect for NPH or any other movement disorder; Young controls group:
- Informed Consent as documented by signature prior to any study related procedures
- Male and female patients alike (matched to group 1)
- Age between 18 and 40 years
- No clinical suspect for NPH or any other movement disorder
Who cannot take part
- Apparent or suspected movement disorder or other known disorder, which might affect normal standing or walking
- Cardiovascular disorders, which might affect physical resilience
- Enrolment of the investigator, his/her family members, employees and other dependent persons (only for patients; no exclusion criteria for controls),
- Pregnant women
- Pre-menopausal state of female patients and probands in groups 1 and 2
- Children and adolescents
Other criteria
- Age limits for the NPH patient group and the matched healthy vonunteers group are 60-100 years
- Age limits for the young healthy volunteers group are 18-40 years
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
20 patients who are diagnosed with NPH receive a set of 5 wearable gyroscopes (IMUs, ZurichMove sensors) for a period of 3 days for measurement and characterization of their walking in an ambulatory setting. At a follow-up 2 weeks to 6 months after CSF diversion surgery, the examination is repeated and improvement is measured. The data will be compared with a healthy group of 20 age- and gender-matched individuals as well a a group of 20 young individuals.
The 3 groups in the trial
- iNPH patientsTreatment being tested
20 patients with completed diagnostics concerning NPH, in which the indication for implantation of a VP shunt for NPH treatment was found by the responsible surgeon independently from the study.
Treatment: Characterization of walking pattern characteristics in an ambulatory setting using wearable IMUs (ZurichMOVE sensors)
- Healthy volunteersExisting treatment, for comparison
20 volunteers, matched with group 1 concerning sex and age.
Treatment: Characterization of walking pattern characteristics in an ambulatory setting using wearable IMUs (ZurichMOVE sensors)
- Young healthy volunteersExisting treatment, for comparison
20 volunteers, matched with group 1 concerning sex only and between 18 and 40 years old.
Treatment: Characterization of walking pattern characteristics in an ambulatory setting using wearable IMUs (ZurichMOVE sensors)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Walking Pattern Characteristics in Normal Pressure Hydrocephalus. A Phase I/II Open-label Single Center Trial to Characterize Disease-specific Walking Patterns Using Wearable Gyroscopes
- Record updated
- 26 April 2024